Cargando…
Therapeutic Potential of Dopamine and Related Drugs as Anti-Inflammatories and Antioxidants in Neuronal and Non-Neuronal Pathologies
Dopamine (DA), its derivatives, and dopaminergic drugs are compounds widely used in the management of diseases related to the nervous system. However, DA receptors have been identified in nonneuronal tissues, which has been related to their therapeutic potential in pathologies such as sepsis or sept...
Autores principales: | Bandala, Cindy, Cárdenas-Rodríguez, Noemi, Mendoza-Torreblanca, Julieta Griselda, Contreras-García, Itzel Jatziri, Martínez-López, Valentín, Cruz-Hernández, Teresita Rocio, Carro-Rodríguez, Jazmín, Vargas-Hernández, Marco Antonio, Ignacio-Mejía, Iván, Alfaro-Rodriguez, Alfonso, Lara-Padilla, Eleazar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966027/ https://www.ncbi.nlm.nih.gov/pubmed/36840015 http://dx.doi.org/10.3390/pharmaceutics15020693 |
Ejemplares similares
-
Antiangiogenic Effect of Dopamine and Dopaminergic Agonists as an Adjuvant Therapeutic Option in the Treatment of Cancer, Endometriosis, and Osteoarthritis
por: Mendoza-Torreblanca, Julieta Griselda, et al.
Publicado: (2023) -
Levetiracetam Mechanisms of Action: From Molecules to Systems
por: Contreras-García, Itzel Jatziri, et al.
Publicado: (2022) -
Evaluation of the Antioxidant Activity of Levetiracetam in a Temporal Lobe Epilepsy Model
por: Ignacio-Mejía, Iván, et al.
Publicado: (2023) -
Levetiracetam Reduced the Basal Excitability of the Dentate Gyrus without Restoring Impaired Synaptic Plasticity in Rats with Temporal Lobe Epilepsy
por: González-H, Guillermo, et al.
Publicado: (2020) -
Synaptic Vesicle Protein 2A Expression in Glutamatergic Terminals Is Associated with the Response to Levetiracetam Treatment
por: Contreras-García, Itzel Jatziri, et al.
Publicado: (2021)